FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208184581> ?p ?o ?g. }

• W3208184581 endingPage "56" @default.
• W3208184581 startingPage "50" @default.
• W3208184581 abstract "Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic autoimmune demyelinating peripheral neuropathy that leads to symmetrical muscular weakness, sensory deficit, hyporeflexia, chronic fatigue, and impaired quality of life (QoL). The current study aims to investigate the effects of gabapentin versus pregabalin on pain, sleep disturbances, and QoL in CIDP patients. Methods This clinical trial was conducted on 40 patients diagnosed with CIDP randomly allocated to treatment with 100-500 mg gabapentin (n=20) or 50-300 mg pregabalin (n=20) both co-medicated with 37.5 mg venlafaxine. The dose of gabapentin/pregabalin was adjusted based on the patient's tolerability/response to the treatment. Visual analogue scale (VAS), Pittsburg Sleep Quality Questionnaire and Short Form Health Survey (SF-36) were filled at baseline, within three, six, nine and 12 months after the interventions to assess pain severity, sleep quality and QoL, respectively. The Iranian Registry of Clinical Trials (IRCT) code: IRCT20200217046523N16, https://fa.irct.ir/search/result?query=IRCT20200217046523N16. Results Gabapentin revealed a dose-dependent efficacy in pain severity (P-value =0.004, r=0.287), sleep quality (P-value 0.05). Co-medication of gabapentin plus venlafaxine could significantly improve sleep quality (P-value =0.009) and QoL (P-value =0.004), but pain severity (P-value =0.796). Pregabalin plus venlafaxine showed statistically significant improvement in pain (P-value =0.046), sleep quality (P-value 0.001) and QoL (P-value =0.03) to pregabalin. Conclusion Based on this study, the co-medication of pregabalin and venlafaxine led to remarkable superior outcomes compared to venlafaxine plus gabapentin in the management of pain, sleep quality, and QoL due to CIDP." @default.
• W3208184581 created "2021-11-08" @default.
• W3208184581 creator A5028056356 @default.
• W3208184581 creator A5057101640 @default.
• W3208184581 creator A5057918688 @default.
• W3208184581 creator A5080818468 @default.
• W3208184581 creator A5087663464 @default.
• W3208184581 date "2021-08-15" @default.
• W3208184581 modified "2023-09-23" @default.
• W3208184581 title "Gabapentin versus Pregabalin for management of chronic inflammatory demyelinating polyradiculoneuropathy." @default.
• W3208184581 cites W1751652836 @default.
• W3208184581 cites W1973485052 @default.
• W3208184581 cites W1974110242 @default.
• W3208184581 cites W1981210662 @default.
• W3208184581 cites W1982511385 @default.
• W3208184581 cites W1983650721 @default.
• W3208184581 cites W1998240591 @default.
• W3208184581 cites W1998256512 @default.
• W3208184581 cites W2007328113 @default.
• W3208184581 cites W2018506852 @default.
• W3208184581 cites W2019169178 @default.
• W3208184581 cites W2035758398 @default.
• W3208184581 cites W2052114512 @default.
• W3208184581 cites W2055564160 @default.
• W3208184581 cites W2064478656 @default.
• W3208184581 cites W2069795112 @default.
• W3208184581 cites W2087064934 @default.
• W3208184581 cites W2088571452 @default.
• W3208184581 cites W2088601889 @default.
• W3208184581 cites W2101941791 @default.
• W3208184581 cites W2110473676 @default.
• W3208184581 cites W2126215689 @default.
• W3208184581 cites W2151487996 @default.
• W3208184581 cites W2160648582 @default.
• W3208184581 cites W2165933810 @default.
• W3208184581 cites W2418594013 @default.
• W3208184581 cites W2622476697 @default.
• W3208184581 cites W2802707556 @default.
• W3208184581 cites W2807671691 @default.
• W3208184581 cites W2937801979 @default.
• W3208184581 cites W2951016976 @default.
• W3208184581 cites W3026456853 @default.
• W3208184581 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8546632" @default.
• W3208184581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34712518" @default.
• W3208184581 hasPublicationYear "2021" @default.
• W3208184581 type Work @default.
• W3208184581 sameAs 3208184581 @default.
• W3208184581 citedByCount "0" @default.
• W3208184581 crossrefType "journal-article" @default.
• W3208184581 hasAuthorship W3208184581A5028056356 @default.
• W3208184581 hasAuthorship W3208184581A5057101640 @default.
• W3208184581 hasAuthorship W3208184581A5057918688 @default.
• W3208184581 hasAuthorship W3208184581A5080818468 @default.
• W3208184581 hasAuthorship W3208184581A5087663464 @default.
• W3208184581 hasConcept C126322002 @default.
• W3208184581 hasConcept C142724271 @default.
• W3208184581 hasConcept C159110408 @default.
• W3208184581 hasConcept C1862650 @default.
• W3208184581 hasConcept C197934379 @default.
• W3208184581 hasConcept C204787440 @default.
• W3208184581 hasConcept C2776466888 @default.
• W3208184581 hasConcept C2776468701 @default.
• W3208184581 hasConcept C2776608144 @default.
• W3208184581 hasConcept C2777107010 @default.
• W3208184581 hasConcept C2778375690 @default.
• W3208184581 hasConcept C2779177272 @default.
• W3208184581 hasConcept C2779526319 @default.
• W3208184581 hasConcept C2779951463 @default.
• W3208184581 hasConcept C2780764818 @default.
• W3208184581 hasConcept C2781161787 @default.
• W3208184581 hasConcept C2991975920 @default.
• W3208184581 hasConcept C42219234 @default.
• W3208184581 hasConcept C71924100 @default.
• W3208184581 hasConceptScore W3208184581C126322002 @default.
• W3208184581 hasConceptScore W3208184581C142724271 @default.
• W3208184581 hasConceptScore W3208184581C159110408 @default.
• W3208184581 hasConceptScore W3208184581C1862650 @default.
• W3208184581 hasConceptScore W3208184581C197934379 @default.
• W3208184581 hasConceptScore W3208184581C204787440 @default.
• W3208184581 hasConceptScore W3208184581C2776466888 @default.
• W3208184581 hasConceptScore W3208184581C2776468701 @default.
• W3208184581 hasConceptScore W3208184581C2776608144 @default.
• W3208184581 hasConceptScore W3208184581C2777107010 @default.
• W3208184581 hasConceptScore W3208184581C2778375690 @default.
• W3208184581 hasConceptScore W3208184581C2779177272 @default.
• W3208184581 hasConceptScore W3208184581C2779526319 @default.
• W3208184581 hasConceptScore W3208184581C2779951463 @default.
• W3208184581 hasConceptScore W3208184581C2780764818 @default.
• W3208184581 hasConceptScore W3208184581C2781161787 @default.
• W3208184581 hasConceptScore W3208184581C2991975920 @default.
• W3208184581 hasConceptScore W3208184581C42219234 @default.
• W3208184581 hasConceptScore W3208184581C71924100 @default.
• W3208184581 hasIssue "4" @default.
• W3208184581 hasLocation W32081845811 @default.
• W3208184581 hasOpenAccess W3208184581 @default.
• W3208184581 hasPrimaryLocation W32081845811 @default.
• W3208184581 hasRelatedWork W1589871607 @default.
• W3208184581 hasRelatedWork W1665446506 @default.

• next